» Articles » PMID: 27833035

Tumor Necrosis Factor α in the Onset and Progression of Leukemia

Overview
Journal Exp Hematol
Specialty Hematology
Date 2016 Nov 12
PMID 27833035
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor alpha (TNF-α), originally described as an anti-neoplastic cytokine, has been found, in apparent contradiction to its name, to play an important role in promoting the development and progression of malignant disease. Targeting TNF-α with TNF antagonists has elicited an objective response in certain solid tumors in phase I and II clinical trials. This review focuses on the relationship of TNF-α expressed by leukemia cells and adverse clinical features of leukemia. TNF-α is involved in all steps of leukemogenesis, including cellular transformation, proliferation, angiogenesis, and extramedullary infiltration. TNF-α is also an important factor in the tumor microenvironment and assists leukemia cells in immune evasion, survival, and resistance to chemotherapy. TNF-α may be a potent target for leukemia therapy.

Citing Articles

Effect of FLT3 ligand on the gene expression of TIM-3, HIF1-α, and TNF-α in an acute myeloid leukemia cell line.

Heidari F, Kazemi-Sefat N, Feizollahi P, Gerdabi S, Pourfathollah A, Ebtekar M Mol Biol Rep. 2025; 52(1):313.

PMID: 40085277 DOI: 10.1007/s11033-025-10396-4.


Risk of hematologic malignancies in psoriasis and rheumatoid arthritis patients using long term TNF-α inhibitors: a retrospective nationwide study.

Song J, Kim S, Kim Y, Park S, Jeong S, Park S Sci Rep. 2025; 15(1):7949.

PMID: 40055388 PMC: 11889116. DOI: 10.1038/s41598-025-90996-z.


Nrf2 Activation as a Therapeutic Target for Flavonoids in Aging-Related Osteoporosis.

Messeha S, Fidudusola F, Gendy S, Latinwo L, Odewumi C, Soliman K Nutrients. 2025; 17(2).

PMID: 39861398 PMC: 11767473. DOI: 10.3390/nu17020267.


Tumor Cell Survival Factors and Angiogenesis in Chronic Lymphocytic Leukemia: How Hot Is the Link?.

Ayoub M, Susin S, Bauvois B Cancers (Basel). 2025; 17(1.

PMID: 39796700 PMC: 11719013. DOI: 10.3390/cancers17010072.


Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia.

Naji N, Sathish M, Karantanos T Cancers (Basel). 2024; 16(23).

PMID: 39682161 PMC: 11640130. DOI: 10.3390/cancers16233974.